PHAGENESIS

Phagenesis is developing a device for the treatment for dysphagia, the inability to swallow safely, that often accompanies stroke or other neuro-deficit diseases. The approach is to harness the brain's own capacity for relearning functions that have been lost through brain damage (via "neuroplasticity" or "cortical remapping"). Focusing initially on the care of stroke patients as they recover in hospital (acute care), Prof Shaheen Hamdy of the University of Manchester, UK, painstakingly devised ... a method of delivering electrical signals from the pharynx (throat) along nerve cells directly to the relevant parts of the brain. The results of his work have been published in top peer-reviewed scientific and medical journals, including The Lancet, the Nature group of publications, and Gastroenterology.
PHAGENESIS
Industry:
Biotechnology Health Care Medical
Founded:
2007-01-01
Address:
Manchester, Manchester, United Kingdom
Country:
United Kingdom
Website Url:
http://www.phagenesis.com
Total Employee:
11+
Status:
Active
Contact:
+44 161 820 4525
Email Addresses:
[email protected]
Total Funding:
29.4 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
MedTech Innovator
MedTech Innovator investment in Non Equity Assistance - Phagenesis
Inventages Venture Capital Investment Inc.
Inventages Venture Capital Investment Inc. investment in Series B - Phagenesis
Inventages Venture Capital Investment Inc.
Inventages Venture Capital Investment Inc. investment in Series B - Phagenesis
Official Site Inspections
http://www.phagenesis.com Semrush global rank: 7.27 M Semrush visits lastest month: 548
- Host name: 141.193.213.20
- IP address: 141.193.213.20
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago

More informations about "Phagenesis"
Phagenesis - Dysphagia Therapy Like No Other
Manufacturer; Phagenesis Ltd, Enterprise House, Manchester Science Park, Manchester, M15 6SE, UK. Indications for Use (Europe/UK/Switzerland): The Phagenyx System (EPSB3 Base Station and PNX-1000 catheter) is to be …See details»
About - Phagenesis
Manufacturer; Phagenesis Ltd, Enterprise House, Manchester Science Park, Manchester, M15 6SE, UK. Indications for Use (Europe/UK/Switzerland): The Phagenyx System (EPSB3 Base Station and PNX-1000 catheter) is to be …See details»
Phagenesis - Crunchbase Company Profile & Funding
Phagenesis is developing a device for the treatment for dysphagia, the inability to swallow safely, that often accompanies stroke or other neuro-deficit diseases. …See details»
Phagenesis Ltd - LinkedIn
At Phagenesis, we are dedicated to transforming the way dysphagia is treated. Dysphagia, or difficulty swallowing, can be a debilitating condition that affects millions of people worldwide.See details»
Phagenesis® | National Foundation of Swallowing Disorders
Apr 25, 2023 Please note: The NFOSD is a nonprofit patient advocacy organization. We do not endorse specific products, treatments, or brands. ... in leading various global clinical education …See details»
Phagenesis - EQT Group
Phagenesis. Catheter-based neurostimulation device for treatment of dysphagia (difficulty to swallow). Key Facts. Sector. ... We are eager to explore how we can achieve great things …See details»
Phagenesis 2025 Company Profile: Valuation, Funding & Investors
Phagenesis General Information Description. Developer of a medical device designed to provide treatment of acute dysphagia. The company's device helps harness the brain's capacity for …See details»
Phagenesis - Funding, Financials, Valuation & Investors - Crunchbase
Phagenesis is engaged in the development of a device to treat dysphagia, a condition that disables the safe swallowing of food. New. Resources. Advanced Search. ... How much …See details»
Phagenesis, a medical device company specializing in the …
Mar 4, 2024 Phagenesis® Ltd, is a private MedTech company co-founded by Dr. Conor Mulrooney and Professor Shaheen Hamdy from the University of Manchester in 2007. …See details»
Phagenesis Appoints Chad Hoskins as Chief Executive …
MANCHESTER, England, Sept. 5, 2024 /PRNewswire/ — Phagenesis, a pioneering company that has developed a first-of-its-kind neurostimulation system to treat swallowing dysfunction, today announced the appointment of Chad …See details»
Phagenesis Company Profile - Office Locations, Competitors
Phagenesis is a company that develops a device to treat dysphagia. Its solution provides treatment for the cause of dysphagia which restores the neurological control of swallowing. …See details»
Phagenesis Company Information - Funding, Investors, and More
Phagenesis Series D (2024, $42M) $42m. Similar startup. F2G Seedtable Score 78. MirrorWeb Seedtable Score 78. Peak Seedtable Score 78. Vsim Seedtable Score 78. Classic Football …See details»
Phagenesis Ltd on LinkedIn: Phagenesis raises $42m to take …
Our $42m raise recognises the passion and committment of the Phagenesis Ltd Team who are our most important asset supporting clinicians introducing #Phagenyx. Big thank you to Alyssa …See details»
Phagenesis | National Foundation of Swallowing Disorders
Company Description: Phagenesis is transforming the lives of patients suffering from neurogenic dysphagia using revolutionary treatments developed through a commitment to scientific and …See details»
Phagenesis - VentureRadar
" Phagenesis has developed the first clinically proven treatment for dysphagia, a debilitating and often lethal condition in which the patient's ability to swallow is damaged. Dysphagia can lead …See details»
Phagenesis - Dysphagia Research Society
Phagenesis is innovating the treatment of neurogenic dysphagia. Founded on 25+ years of scientific and clinical research, the Phagenyx® Pharyngeal Electrical Stimulation System …See details»
Phagenesis, a medical device company specializing in the …
Manufacturer; Phagenesis Ltd, Enterprise House, Manchester Science Park, Manchester, M15 6SE, UK. Indications for Use (Europe/UK/Switzerland): The Phagenyx System (EPSB3 Base …See details»
Phagenesis ernennt Chad Hoskins zum Chief Executive Officer …
Manchester, UK – 5. September 2024 – Das britische Pionierunternehmen Phagenesis, das ein neuartiges Neurostimulationssystem zur Behandlung von Schluckstörungen entwickelt hat, …See details»
Build for the User, Not the Spec Sheet: Interview with Phagenesis …
After more than a decade at the helm of Phagenesis, Reinhard Krickl is stepping aside as CEO, setting the stage for the company to spread its wings in the United States. An engineer and an …See details»
Largest real-world study of Phagenyx® demonstrates significant …
Manufacturer; Phagenesis Ltd, Enterprise House, Manchester Science Park, Manchester, M15 6SE, UK. Indications for Use (Europe/UK/Switzerland): The Phagenyx System (EPSB3 Base …See details»